Tickers

AKAM — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-23 06:28:13.235154 UTC · finished 2026-09-23 06:36:06.730706 UTC

1. Composite Trajectory Verdict

Given AKAM's capital-intensive infrastructure model and reliance on recurring revenue, the cash flow statement matters most because operating cash flow funds network expansion, debt service, and shareholder returns.

Composite Trajectory: Mixed

Annual revenue has grown 5% in each of the last two years, but GAAP net income has declined for two consecutive years (down 7.8% in 2024 and 10.5% in 2025) and operating margin compressed from 17% to 13% (10-K 2025-12-31, Consolidated Statements of Operations). Quarterly results show accelerating margin deterioration: Q2 2026 operating margin fell to 7% from 15% in Q2 2025, with cost of revenue rising to 44% of revenue from 41% (10-Q 2026-06-30, MD&A Results of Operations). Operating cash flow has been stable at ~$1.5B annually (10-K 2025-12-31, Consolidated Statements of Cash Flows), while the balance sheet shows rising leverage (convertible notes up 16%, operating lease liabilities up 44%) but only two annual periods are available, limiting trend assessment (10-K 2025-12-31, Consolidated Balance Sheets). The combination of stable cash generation, deteriorating profitability, and increasing leverage yields a mixed trajectory.

2. Red Flags

  • Net income declined for two consecutive years despite revenue growth: -7.8% in 2024 (to $504.9M) and -10.5% in 2025 (to $452.0M) (10-K 2025-12-31, Consolidated Statements of Operations).
  • GAAP operating margin compressed from 17% (2023) to 13% (2024-2025), while non-GAAP operating margin remained flat at ~30%, widening the gap (10-K 2025-12-31, Use of Non-GAAP Financial Measures).
  • Quarterly operating margin collapsed: 7% in Q2 2026 vs 15% in Q2 2025; six-month margin 9% vs 15% (10-Q 2026-06-30, MD&A Results of Operations).
  • Cost of revenue as a percentage of revenue jumped to 44% in Q2 2026 from 41% in Q2 2025, driven by co-location, network build-out, and stock-based compensation (10-Q 2026-06-30, MD&A Cost of Revenue).
  • Convertible senior notes outstanding increased to $4.1B at Dec 31, 2025 from $3.5B at Dec 31, 2024, while cash and marketable securities rose only modestly to $1.9B from $1.9B (10-K 2025-12-31, Consolidated Balance Sheets; Note 11 Debt).
  • Restructuring charges have recurred for three straight years: $56.6M (2023), $95.4M (2024), $58.1M (2025), and continued into H1 2026 ($2.0M) (10-K 2025-12-31, Note 10 Restructuring; 10-Q 2026-06-30, Restructuring Charge).
  • Stock-based compensation expense rose sharply: $328M (2023), $393M (2024), $459M (2025), with further increases in Q2 2026 due to a new retirement benefit (10-K 2025-12-31, Stock-Based Compensation Expense; 10-Q 2026-06-30, Research and Development Expenses).
  • Amortization of acquired intangible assets accelerated: $66.8M (2023), $92.1M (2024), $111.1M (2025) (10-K 2025-12-31, Amortization of Acquired Intangible Assets).
  • Effective tax rate volatility: 16% (2023), 14% (2024), 25% (2025) (10-K 2025-12-31, Provision for Income Taxes).
  • Operating cash flow flatlined in 2025 ($1,518.8M) vs 2024 ($1,519.2M) despite 5% revenue growth (10-K 2025-12-31, Consolidated Statements of Cash Flows).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Annual revenue grew 5% in both 2024 and 2025, reaching $4.21B in 2025 (10-K 2025-12-31, Consolidated Statements of Operations). However, GAAP net income fell 7.8% in 2024 and 10.5% in 2025, driven by rising cost of revenue (41% of revenue in 2024-2025 vs 40% in 2023), increasing amortization of acquired intangibles (2% to 3% of revenue), and a spike in effective tax rate to 25% in 2025 from 14% in 2024. Quarterly trends worsened: Q2 2026 operating income dropped 47% YoY to $80.3M, with operating margin halving to 7% from 15%; six-month operating margin fell to 9% from 15% (10-Q 2026-06-30, MD&A Results of Operations). All major operating expense categories (R&D, sales & marketing, G&A) increased as a percentage of revenue in the most recent quarter.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Stable

Annual operating cash flow has been remarkably steady: $1.35B (2023), $1.52B (2024), $1.52B (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). Investing cash outflows have moderated each year: -$1.85B (2023), -$0.80B (2024), -$0.54B (2025), reflecting lower acquisition spending and reduced marketable securities purchases. Financing cash flows were negative in 2024 (-$0.68B) and 2025 (-$0.59B) due to share repurchases ($557M and $800M) and debt repayments, offset partially by convertible note issuances in 2025 ($1.7B issued, $1.15B repaid). The net cash position increased to $931M at end of 2025 from $519M at end of 2024, largely due to the net proceeds from the 2033 notes. Quarterly cash flow statements for 2026 are not available in the provided filings.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Insufficient Data

Only two annual balance sheets are provided (Dec 31, 2024 and Dec 31, 2025), allowing a single year-over-year comparison but not a trend. Total assets grew 11% to $11.5B, driven by property & equipment (+17% to $2.33B) and operating lease right-of-use assets (+46% to $1.47B) (10-K 2025-12-31, Consolidated Balance Sheets). Total liabilities rose 18% to $6.5B, primarily from a 16% increase in convertible senior notes ($4.11B vs $3.55B) and a 44% increase in operating lease liabilities ($1.57B vs $1.09B). Stockholders' equity increased 2% to $4.98B. Cash and marketable securities combined were roughly flat at ~$1.9B. Without a third annual period or quarterly balance sheets, a trajectory cannot be determined.

6. Data Gaps

  • Quarterly cash flow statements for Q1 2026, Q2 2026, Q3 2025, Q2 2025 (10-Q 2026-06-30 truncated; other 10-Qs not provided)
  • Quarterly balance sheets for 2026 periods (10-Q 2026-06-30 truncated; other 10-Qs not provided)
  • Annual balance sheet for 2023 (10-K 2025-12-31 only shows 2024 and 2025)
  • Full 10-Q filings for periods 2025-09-30, 2025-06-30, 2026-03-31 (referenced but not included in provided text)
  • Free cash flow breakdown (capital expenditures vs operating cash flow) for quarterly periods
  • Revenue by solution category for quarters prior to Q2 2026 (only annual and Q2 2026 disclosed)
  • Detailed debt maturity schedule beyond 2025 (Note 11 provides summary but not full schedule)
  • Segment-level profitability (company reports single segment)
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status